Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...

VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces the release of Volition's new lung cancer primer, "Lung Cancer: Hope of a Brighter Tomorrow." The report ...

EDDIE JORDAN was the Irish underdog who brought rock’n’roll energy to Formula One – and helped make Katie Price a star. The ...

Science Daily reserves all rights in and to any Science Daily logos, trademarks or trade names contained in any RSS feed, and your right to use these Science Daily logos, trademarks or trade names ...

Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular dysfunction associated with obstructive sleep apnea ...

Experts worry that restrictions on immigration could lead to a shortage of caregivers as the U.S. population grows older and ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

He is signed to Nike, H-E-B, and Louis Vuitton, which is already an impressive endorsement catalog. His signature sneakers, ...

In the corners of social media dominated by wellness content, influencers recommend an assortment of treatments and products ...

ZERO Prostate Cancer (ZERO), the nation's leading prostate cancer organization and voice of the prostate cancer community, ...

2-Year U.S. Treasury Note Continuous Contract $103.594 0.059 0.06% 5-Year U.S. Treasury Note Continuous Contract $108.164 0.148 0.14% 10-Year U.S. Treasury Note Continuous Contract $111.359 0.188 ...